Drug
 
Aliases:
Coumadin
Marevan

Topic aliases are alternate phrasings for a particular topic.


Vitamin K antagonist inhibiting the production of vitamin K dependent clotting factors II, VII, IX, and X. Indicated for therapeutic anticoagulation. Reversal is achieved through either witholding ~5days prior to elective surgery, with or without alternative short-duration anticoagulation, or reversed closer to surgery with prothrombinex, FFP, and vitamin K.

Improve to correct grammar or spelling, but do not significantly alter the substance of the original author's text.


Cancel
attachment
Endorsed by , more...
Locksmallsmush Private
Locksmallsmush only
Locksmallsmush only


attachment
Locksmallsmush Private
Locksmallsmush only
Locksmallsmush only


Warfarin is contraindicated in pregnancy refl.in/2a . Warfarin embryopathy occurs in approximately 5% of fetuses exposed to warfarin between 6-13 weeks. Warfarin embryopathy is variable in severity and ranges from mild nasal flattening to severe mid face flattening with shortened limbs (dwarfism). Exposure in the second or third trimester carries an additional 5% risk of fetal intracerebral haemorrhage.

Improve to correct grammar or spelling, but do not significantly alter the substance of the original author's text.


Cancel
attachment
Endorsed by , more...
Locksmallsmush Private
Locksmallsmush only
Locksmallsmush only


Day of surgery: If INR < 1.5 most surgery can generally proceed, but may need to discuss with surgeon. If INR > 1.5, defer surgery, or if surgery is urgent, give Prothrombinex HT (25–50 IU/kg) plus 150–300 mL fresh frozen-plasma or 10–15 mL/kg of fresh frozen-plasma if Prothrombinex-HT is not used. refl.in/i4

Improve to correct grammar or spelling, but do not significantly alter the substance of the original author's text.


Cancel
attachment
Endorsed by , more...
Locksmallsmush Private
Locksmallsmush only
Locksmallsmush only


Recommencing warfarin:
If no risk factors exist and the patient has a previous known stable dose of Warfarin, Recommence on the same dose that the patient previously had a stable therapeutic INR, assuming that no new risk factors exist.
No “loading” dose is required in this situation. refl.in/ob

Improve to correct grammar or spelling, but do not significantly alter the substance of the original author's text.


Cancel
attachment
Endorsed by , more...
Locksmallsmush Private
Locksmallsmush only
Locksmallsmush only


Warfarin reversal guidelines by the Australasian Society of Thrombosis and Haemostasis 2004 refl.in/i4

Improve to correct grammar or spelling, but do not significantly alter the substance of the original author's text.


Cancel
attachment
Endorsed by , more...
Locksmallsmush Private
Locksmallsmush only
Locksmallsmush only